Page 290 - ATP-P 11th Ed
P. 290

Acetaminophen – PO (Tylenol )
                              ®
        Description: Nonnarcotic analgesic and antipyretic. Blocks generation of pain impulses in
        the CNS by preventing sensitization of pain receptors.
        Indications: Mild pain or fever, febrile reactions from blood transfusions
        Dose: 325–650mg PO q4–6hr; or 1g PO every 6–8hr
        Contraindications:
        •  Individuals with hypersensitivity to drug.
        •  Cautious use in history of excess alcohol use
        •  Chronic liver damage
        Pregnancy Category B
        Side-effects:
        •  Rash
        •  Urticaria
        Adverse reactions:
        •  Hemolytic anemia
   SECTION 3  •  Liver damage
        TMEP use:
        •  Bronchitis/Pneumonia Protocol
        •  Malaria Protocol
        •  Pain Management Protocol
        •  Administration of Blood and Blood Products Protocol

        Acetazolamide (Diamox )
                          ®
              GROUNDING medication for personnel on flight status
        Description: Non-diuretic antihypertensive (carbonic anhydrase inhibitor)
        Indications:
        •  Prevention and/or amelioration of symptoms associated with acute mountain sickness
          in climbers attempting rapid ascent and/or in those who are very susceptible to acute
          mountain sickness despite gradual ascent. For maximum benefit begin regimen 7 days
          prior to ascent. Of minimal benefit in Rx of AMS, HACE, or HAPE.
        •  Treatment of acute high altitude illness
        Dose (Human):
        •  125–250mg bid, 24hr prior to ascent, continuing for 48hr after ascent. Prevention and/
          or amelioration benefits are nominal once ascent has commenced.
        •  If the 500mg sustained release tablet is used, dose is 500mg q24hr.
             K9 Dose:
        •  250mg bid 24hr prior to ascent, continuing for 48hr after ascent.
        •  If the 500mg sustained release tablet is used, dose is 500mg every q24hr.


          280  SECTION 3   RECOMMENDED DRUG LIST (RDL)
   285   286   287   288   289   290   291   292   293   294   295